BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19481806)

  • 1. Trimeric coiled-coil domain of human pulmonary surfactant protein D enhances zinc-binding ability and biologic activity of soluble TRAIL.
    Wu X; Li P; Qian C; Li O; Zhou Y
    Mol Immunol; 2009 Jul; 46(11-12):2381-8. PubMed ID: 19481806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducing rigid local structure around the zinc-binding region by hydrophobic interactions enhances the homotrimerization and apoptotic activity of zinc-free TRAIL.
    Lee HW; Kim TI; Chan KH; Kwon MH; Kim JS; Jin M; Kim YS
    Biochem Biophys Res Commun; 2007 Oct; 362(3):766-72. PubMed ID: 17765202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of expression level and bioactivity of soluble tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) by a novel zinc ion feeding strategy.
    Sun AY; Shen YL; Yin JC; Zhang H; Tang YN; Wei DZ
    Biotechnol Lett; 2006 Aug; 28(15):1215-9. PubMed ID: 16799759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pVAX1 plasmid vector-mediated gene transfer of soluble TRAIL suppresses human hepatocellular carcinoma growth in nude mice.
    Zhang Y; Ma CH; Liu H; Zhang XM; Sun WS
    Acta Biochim Pol; 2007; 54(2):307-13. PubMed ID: 17546204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C repeats of the streptococcal M1 protein achieve the human serum albumin binding ability by flanking regions which stabilize the coiled-coil conformation.
    Gubbe K; Misselwitz R; Welfle K; Reichardt W; Schmidt KH; Welfle H
    Biochemistry; 1997 Jul; 36(26):8107-13. PubMed ID: 9201959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior serum half life of albumin tagged TNF ligands.
    Müller N; Schneider B; Pfizenmaier K; Wajant H
    Biochem Biophys Res Commun; 2010 Jun; 396(4):793-9. PubMed ID: 20447380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice.
    Ma H; Liu Y; Liu S; Xu R; Zheng D
    Hepatology; 2005 Dec; 42(6):1355-63. PubMed ID: 16317690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
    Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and physicochemical evaluation of the conformational stability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Youn YS; Shin MJ; Chae SY; Jin CH; Kim TH; Lee KC
    Biotechnol Lett; 2007 May; 29(5):713-21. PubMed ID: 17318333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Lin Z; Lei H; Cao P
    Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L.
    Berg D; Lehne M; Müller N; Siegmund D; Münkel S; Sebald W; Pfizenmaier K; Wajant H
    Cell Death Differ; 2007 Dec; 14(12):2021-34. PubMed ID: 17703232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation.
    Cordier F; Vinolo E; Véron M; Delepierre M; Agou F
    J Mol Biol; 2008 Apr; 377(5):1419-32. PubMed ID: 18313693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific PEGylation of a mutated-cysteine residue and its effect on tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL).
    Pan LQ; Wang HB; Lai J; Xu YC; Zhang C; Chen SQ
    Biomaterials; 2013 Dec; 34(36):9115-23. PubMed ID: 23981355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-ion-dependent GFP emission in vivo by combining a circularly permutated green fluorescent protein with an engineered metal-ion-binding coiled-coil.
    Mizuno T; Murao K; Tanabe Y; Oda M; Tanaka T
    J Am Chem Soc; 2007 Sep; 129(37):11378-83. PubMed ID: 17722917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling.
    Moriwaki K; Noda K; Furukawa Y; Ohshima K; Uchiyama A; Nakagawa T; Taniguchi N; Daigo Y; Nakamura Y; Hayashi N; Miyoshi E
    Gastroenterology; 2009 Jul; 137(1):188-98, 198.e1-2. PubMed ID: 19361506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye.
    Secchiero P; Lamberti G; Corallini F; Melloni E; Guarnotta C; Sebastiani A; Zauli G
    J Cell Physiol; 2009 Jan; 218(1):199-204. PubMed ID: 18780288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
    Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
    Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma.
    Lamoureux F; Picarda G; Garrigue-Antar L; Baud'huin M; Trichet V; Vidal A; Miot-Noirault E; Pitard B; Heymann D; Rédini F
    Cancer Res; 2009 Jan; 69(2):526-36. PubMed ID: 19147566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.
    Mahajan L; Madan T; Kamal N; Singh VK; Sim RB; Telang SD; Ramchand CN; Waters P; Kishore U; Sarma PU
    Int Immunol; 2008 Aug; 20(8):993-1007. PubMed ID: 18628238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.